Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I J Stratford

Showing results (1-10 of 201) with videos related to

Pageof 21
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 1, 1982
Mechanisms of hypoxic cell radiosensitization and the development of new sensitizersI J Stratford
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Concepts and developments in radiosensitization of mammalian cellsI J Stratford
British Journal of Cancer|July 1, 1978
Split dose cytotoxic experiments with misonidazoleI J Stratford
BJR Supplement|January 1, 1992
Bioreductive drugs in cancer therapyI J Stratford
Anti-Cancer Drug Design|October 2, 1998
Bioreductive drugs into the next millenniumI J Stratford, P Workman
International Journal of Radiation Oncology, Biology, Physics|December 9, 1998
The influence of elevated levels of platelet-derived endothelial cell growth factor/thymidine phosphorylase on tumourigenicity, tumour growth, and oxygenationL Griffiths, I J Stratford
The Journal of Pharmacy and Pharmacology|December 1, 1973
Proceedings: Inactivation by gamma-rays of Bacillus megaterium spores suspended in aqueous solutions of ethanol, acetone and 1,4-dioxane of widely varying concentrationsI J Stratford, A Tallentire
The British Journal of Cancer. Supplement|June 1, 1978
Some factors affecting the specific toxicity of misonidazole towards hypoxic mammalian cellsI J Stratford, P Gray
Cancer Metastasis Reviews|June 1, 1993
The experimental development of bioreductive drugs and their role in cancer therapyP Workman, I J Stratford
The Journal of Pharmacy and Pharmacology|December 1, 1972
Non-aqueous liquids as modifiers of lethal damage induced by Bacillus megaterium spores by gamma-raysI J Stratford, A Tallentire
Pageof 21

Showing results (1-10 of 201) with videos related to

Sort By:
Pageof 21
International Journal of Radiation Oncology, Biology, Physics|March 1, 1982
Mechanisms of hypoxic cell radiosensitization and the development of new sensitizersI J Stratford
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Concepts and developments in radiosensitization of mammalian cellsI J Stratford
British Journal of Cancer|July 1, 1978
Split dose cytotoxic experiments with misonidazoleI J Stratford
BJR Supplement|January 1, 1992
Bioreductive drugs in cancer therapyI J Stratford
Anti-Cancer Drug Design|October 2, 1998
Bioreductive drugs into the next millenniumI J Stratford, P Workman
International Journal of Radiation Oncology, Biology, Physics|December 9, 1998
The influence of elevated levels of platelet-derived endothelial cell growth factor/thymidine phosphorylase on tumourigenicity, tumour growth, and oxygenationL Griffiths, I J Stratford
The Journal of Pharmacy and Pharmacology|December 1, 1973
Proceedings: Inactivation by gamma-rays of Bacillus megaterium spores suspended in aqueous solutions of ethanol, acetone and 1,4-dioxane of widely varying concentrationsI J Stratford, A Tallentire
The British Journal of Cancer. Supplement|June 1, 1978
Some factors affecting the specific toxicity of misonidazole towards hypoxic mammalian cellsI J Stratford, P Gray
Cancer Metastasis Reviews|June 1, 1993
The experimental development of bioreductive drugs and their role in cancer therapyP Workman, I J Stratford
The Journal of Pharmacy and Pharmacology|December 1, 1972
Non-aqueous liquids as modifiers of lethal damage induced by Bacillus megaterium spores by gamma-raysI J Stratford, A Tallentire
Pageof 21